Why is Zenotech Lab. falling/rising?

As of 19-Sep, Zenotech Laboratories Ltd is experiencing a decline in its stock price, currently at 52.32, reflecting a decrease of 0.59 or 1.12%. The stock has underperformed its sector by 1.39% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has fallen by 5.53%, and it has shown a significant year-to-date decline of 27.28%. Additionally, the company's delivery volume has decreased by 19.61% compared to the 5-day average, indicating a drop in investor participation. Despite having a low Debt to EBITDA ratio of 0.90, which suggests a strong ability to service debt, the company has reported poor financial performance, with net sales falling by 10.4% and profits declining by 48.8% over the past year.
In the broader market context, the Sensex has increased by 0.88% over the past week, contrasting sharply with Zenotech's negative performance. While the benchmark has shown a positive return of 5.74% year-to-date, Zenotech's returns have been significantly lower, highlighting its underperformance relative to the market. The stock's valuation appears expensive with a Price to Book Value of 3.4, and its return on equity stands at a low 4.3, further contributing to investor skepticism. Overall, the combination of poor financial results, declining investor interest, and a lack of growth prospects has led to the stock's downward trajectory.